Sr. Director, Business Development & Corporate Strategy

About GondolaBio

GondolaBio is a standalone rare disease innovator, formed as a spin-out from BridgeBio, with independent governance, capital, and leadership. GondolaBio is focused on developing breakthrough therapeutics for diseases with genetically defined targets. The portfolio includes several clinical-stage programs, with growing franchises across genetic specialties, neurology, and renal. The company leverages cutting-edge biological research to discover, create, test, and deliver transformative medicines to treat patients, with a purpose-built discovery and development engine. The company is well capitalized, with funding from leading investors. 

Who You Are

You are a strategy-first, transaction-capable biopharma professional who combines independent judgment, rigorous analytics, scientific literacy, and commercial insight. You can compare very different assets on a common basis, identify the most compelling strategic choices, and translate uncertainty into actionable recommendations. You are comfortable modeling and structuring complex transactions without treating deal execution as the only path to value creation. You thrive in lean teams, work closely with R&D and Finance, and approach every choice through patient impact and long-term value.

Key Responsibilities

Integrated portfolio strategy: Develop cross-portfolio analyses to inform strategic priorities, portfolio balance, capital allocation, and value creation across a multi-asset, multi-therapeutic-area portfolio. Evaluate financing and partnering pathways in collaboration with R&D, Finance, and program teams.

Strategy and decision support: Serve as a strategic and analytical partner to the leadership team; frame enterprise-level questions and translate incomplete scientific, commercial, and financial information into clear, decision-ready recommendations, including time-sensitive opportunities.

External opportunity evaluation: Partner with internal scientific and program teams on sourcing and screening external assets and technologies. Lead market attractiveness, competitive, strategic-fit, and financial assessments, with scientific colleagues providing technical diligence expertise.

Valuation and deal economics: Own rigorous rNPV/NPV, probability-weighted, and scenario analysis for partnerships, in-licensing, and other strategic transactions. Quantify risk-adjusted returns, value-inflection points, and tradeoffs among deal terms such as upfronts, milestones, royalties, and rights.

Strategic transactions and structuring: Evaluate a broad range of transaction structures, including licenses, options, co-development partnerships, and other strategic transactions. Support transaction strategy, due diligence, negotiation preparation, and economic terms in coordination with Business Development, Finance, and external advisors.

Deal, partner, and investor intelligence: Build actionable intelligence on transaction precedents, potential partners, and industry pipelines and priorities. Maintain fit-for-purpose benchmarks and decision tools, leveraging available external datasets.

Competitive intelligence and asset strategy: Lead the commercial and strategic interpretation of competitive landscapes, treatment paradigms, and market dynamics. For each asset, assess strategic role, differentiated value, and partnering considerations.

AI-enabled strategic intelligence: Pilot and use advanced AI, digital data sources, and analytical workflows to accelerate market mapping, competitor monitoring, asset screening, scenario analysis, and production of reliable, auditable decision materials; apply appropriate verification and confidentiality standards.

Cross-functional collaboration and governance: Work closely with Business Development, program leaders, R&D, and Finance, maintaining clear ownership boundaries. Lead the analytical foundation for portfolio and Board discussions and partner with Portfolio Positioning & Communications on consistent external narratives and transaction materials.

Preferred Education & Experience

• Advanced degree (Ph.D., M.D., MBA, or equivalent) preferred; sufficient scientific depth to work credibly with R&D and scientific teams.
• Approximately 10+ years in biopharma corporate strategy, business/corporate development, healthcare investment banking, transaction advisory, or life-sciences strategy consulting; exceptional candidates with equivalent relevant experience considered.
• Exceptional strategic judgment and ability to synthesize scientific, market, and financial information into crisp recommendations for executive and Board audiences.
• Demonstrated hands-on financial modeling, rNPV/scenario analysis, and commercial valuation skills; familiarity with transaction comparables and capital allocation.
• Meaningful exposure to licensing, M&A, options, co-development, or other complex transactions; ability to contribute to structuring and negotiation preparation.
• Strong cross-functional influence and comfort operating independently in a lean, fast-paced, decentralized environment.
• Fluency with modern data, research, and AI-enabled analytical workflows, paired with rigorous source verification and good judgment on confidential information.

Nice-to-Haves

• Experience in rare and genetic diseases.
• Experience with multi-asset transactions, portfolio prioritization, and creative deal structures.
• Ability to establish lean, high-quality external intelligence and deal-benchmarking processes.
• Experience in decentralized or affiliate-based operating models.

No matter your role at GondolaBio, successful team members are

• Patient Champions who put patients first, uphold strict ethical standards, and anchor decisions in clinical and scientific integrity.
• Entrepreneurial Operators who take ownership and drive toward practical solutions, while exercising sound judgment, respecting established processes, and aligning with teammates and leadership.
• Truth Seekers who are rigorous, detail-oriented, and intellectually honest—comfortable challenging assumptions, engaging with data, and updating their views based on evidence.
• Collaborative Thinkers who work effectively in data-driven, interdisciplinary environments; listen actively; and welcome questions, debate, and constructive challenge as essential to better decision-making.
• Individuals Who Inspire Excellence in themselves and those around them.
• High-quality Executors who deliver against goals and milestones with precision, accountability, and appropriate urgency—without compromising scientific rigor or team alignment.

What We Offer

• Patient Days, where we are fortunate to hear directly from individuals living with the conditions we are seeking to impact throughout the year and learn how we can improve our efforts
• A culture inspired by our values: put patients first, think independently, be radically transparent, every minute counts, and let the science speak
• An unyielding commitment to always putting patients first
• A decentralized model that enables our program teams to focus on advancing science and helping patients. Our affiliate structure is designed to eliminate bureaucracy and put decision-making power in the hands of those closest to the science
• A place where you own the vision – both for your program and your own career path
• A collaborative, fast-paced, data-driven environment where we inspire ourselves and each other to always perform at the top of our game
• Access to learning and development resources to help you get in the best professional shape of your life
• Robust and market-competitive compensation & benefits package (Base, Performance Bonus, Equity, health, welfare & retirement programs)
• Flexible PTO
• Rapid career advancement for strong performers
• Potential ability to work on multiple GondolaBio Pharma programs across multiple therapeutic areas over time
• Commitment to Diversity, Equity & Inclusion

Compensation

The base pay range for this position is $313,000 - $340,000 per year. The actual compensation offered will be determined based on a number of job-related factors, including experience, skills, qualifications, and location. A bonus plan and equity will also be offered.

GondolaBio ServiceCo is an equal opportunity employer. All applicants will be considered for employment without attention to race, color, religion, sex, sexual orientation, gender identity, national origin, veteran or disability status. Employees of BridgeBio and all affiliated companies should work through their managers to inquire about and learn more about this role.

Fraud Alert: We are aware of employment scams where individuals pose as representatives of GondolaBio and make false use of our company name to defraud job seekers. To protect yourself, please note that our official corporate website is https://gondolabio.com/; our careers page is https://gondolabio.com/#careers; our LinkedIn page is https://www.linkedin.com/company/gondolabio/. Please visit these links for official information from GondolaBio. Communication from any other variant is fraudulent. GondolaBio does not conduct interviews via text message/messaging platforms, will not ask you to download anything as part of your interview, will never request any form of payment, provide upfront payments of any kind, and does not make job offers without interviews.